{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:33:29Z","timestamp":1789385609464,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Sciences foundation of China","doi-asserted-by":"crossref","award":["81100329"],"award-info":[{"award-number":["81100329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Sciences foundation of China","doi-asserted-by":"crossref","award":["81472372"],"award-info":[{"award-number":["81472372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13045-016-0300-3","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T20:50:39Z","timestamp":1470948639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["MiR-124-3p\/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML"],"prefix":"10.1186","volume":"9","author":[{"given":"Yu-xiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-hui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-ji","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,12]]},"reference":[{"issue":"4","key":"300_CR1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nsmb.2519","volume":"20","author":"NJ Kershaw","year":"2013","unstructured":"Kershaw NJ, Murphy JM, Liau NP, Varghese LN, Laktyushin A, Whitlock EL, Lucet IS, Nicola NA, Babon JJ. SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition. Nat Struct Mol Biol. 2013;20(4):469\u201376.","journal-title":"Nat Struct Mol Biol"},{"key":"300_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2741\/S372","volume":"5","author":"Z Culig","year":"2013","unstructured":"Culig Z. Suppressors of cytokine signalling-3 and -1 in human carcinogenesis. Front Biosci (Schol Ed). 2013;5:277\u201383.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"3","key":"300_CR3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbrc.2004.12.074","volume":"327","author":"CV Ramana","year":"2005","unstructured":"Ramana CV, Kumar A, Enelow R. Stat1-independent induction of SOCS-3 by interferon-gamma is mediated by sustained activation of Stat3 in mouse embryonic fibroblasts. Biochem Biophys Res Commun. 2005;327(3):727\u201333.","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"300_CR4","doi-asserted-by":"crossref","first-page":"9324","DOI":"10.1073\/pnas.161271798","volume":"98","author":"AW Roberts","year":"2001","unstructured":"Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, Nicola NA, Metcalf D, Hilton DJ, Alexander WS. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci U S A. 2001;98(16):9324\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"300_CR5","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.18632\/oncotarget.3443","volume":"6","author":"JH Lee","year":"2015","unstructured":"Lee JH, Kim C, Sethi G, Ahn KS. Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel. Oncotarget. 2015;6(8):6386\u2013405.","journal-title":"Oncotarget"},{"issue":"3","key":"300_CR6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00432-014-1838-5","volume":"141","author":"G Li","year":"2015","unstructured":"Li G, Xu J, Wang Z, Yuan Y, Li Y, Cai S, He Y. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients. J Cancer Res Clin Oncol. 2015;141(3):443\u201352.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"42","key":"300_CR7","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1038\/sj.onc.1208788","volume":"24","author":"Y Niwa","year":"2005","unstructured":"Niwa Y, Kanda H, Shikauchi Y, Saiura A, Matsubara K, Kitagawa T, Yamamoto J, Kubo T, Yoshikawa H. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK\/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene. 2005;24(42):6406\u201317.","journal-title":"Oncogene"},{"issue":"5","key":"300_CR8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0092-8674(00)80049-5","volume":"98","author":"JC Marine","year":"1999","unstructured":"Marine JC, McKay C, Wang D, Topham DJ, Parganas E, Nakajima H, Pendeville H, Yasukawa H, Sasaki A, Yoshimura A, Ihle JN. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell. 1999;98(5):617\u201327.","journal-title":"Cell"},{"issue":"21","key":"300_CR9","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1038\/sj.onc.1206381","volume":"22","author":"MK Sarna","year":"2003","unstructured":"Sarna MK, Ingley E, Busfield SJ, Cull VS, Lepere W, McCarthy DJ, Wright MJ, Palmer GA, Chappell D, Sayer MS, Alexander WS, Hilton DJ, Starr R, Watowich SS, Bittorf T, Klinken SP, Tilbrook PA. Differential regulation of SOCS genes in normal and transformed erythroid cells. Oncogene. 2003;22(21):3221\u201330.","journal-title":"Oncogene"},{"issue":"4","key":"300_CR10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2141.2008.07072.x","volume":"141","author":"D Capello","year":"2008","unstructured":"Capello D, Deambrogi C, Rossi D, Lischetti T, Piranda D, Cerri M, Spina V, Rasi S, Gaidano G, Lunghi M. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders. Br J Haematol. 2008;141(4):504\u201311.","journal-title":"Br J Haematol"},{"issue":"11","key":"300_CR11","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.7314\/APJCP.2014.15.11.4555","volume":"15","author":"HA Al-Jamal","year":"2014","unstructured":"Al-Jamal HA, Jusoh SA, Yong AC, Asan JM, Hassan R, Johan MF. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells. Asian Pac J Cancer Prev. 2014;15(11):4555\u201361.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"300_CR12","doi-asserted-by":"crossref","first-page":"e0135259","DOI":"10.1371\/journal.pone.0135259","volume":"10","author":"YX Liu","year":"2015","unstructured":"Liu YX, Dong X, Gong F, Su N, Li SB, Zhang HT, Liu JL, Xue JH, Ji SP, Zhang ZW. Promotion of erythropoietic differentiation in hematopoietic stem cells by SOCS3 knock-down. PLoS One. 2015;10(8):e0135259.","journal-title":"PLoS One"},{"key":"300_CR13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2162-3619-3-17","volume":"3","author":"L Xu","year":"2014","unstructured":"Xu L, Xu Y, Jing Z, Wang X, Zha X, Zeng C, Chen S, Yang L, Luo G, Li B, Li Y. Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia. Exp Hematol Oncol. 2014;3:17.","journal-title":"Exp Hematol Oncol"},{"key":"300_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-014-0083-3","volume":"7","author":"A Dzikiewicz-Krawczyk","year":"2014","unstructured":"Dzikiewicz-Krawczyk A. MicroRNA-binding site polymorphisms in hematological malignancies. J Hematol Oncol. 2014;7:83.","journal-title":"J Hematol Oncol"},{"key":"300_CR15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-015-0162-0","volume":"8","author":"S Naidu","year":"2015","unstructured":"Naidu S, Magee P, Garofalo M. MiRNA-based therapeutic intervention of cancer. J Hematol Oncol. 2015;8:68.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"300_CR16","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1182\/blood-2002-01-0073","volume":"100","author":"I Sakai","year":"2002","unstructured":"Sakai I, Takeuchi K, Yamauchi H, Narumi H, Fujita S. Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells. Blood. 2002;100(8):2926\u201331.","journal-title":"Blood"},{"issue":"2","key":"300_CR17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.leukres.2004.06.006","volume":"29","author":"K Takeuchi","year":"2005","unstructured":"Takeuchi K, Sakai I, Narumi H, Yasukawa M, Kojima K, Minamoto Y, Fujisaki T, Tanimoto K, Hara M, Numata A, Gondo H, Takahashi M, Fujii N, Masuda K, Fujita S. Expression of SOCS3 mRNA in bone marrow cells from CML patients associated with cytogenetic response to IFN-alpha. Leuk Res. 2005;29(2):173\u20138.","journal-title":"Leuk Res"},{"issue":"7","key":"300_CR18","doi-asserted-by":"crossref","first-page":"e69478","DOI":"10.1371\/journal.pone.0069478","volume":"8","author":"L An","year":"2013","unstructured":"An L, Liu Y, Wu A, Guan Y. microRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma. PLoS One. 2013;8(7):e69478.","journal-title":"PLoS One"},{"key":"300_CR19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.biopha.2016.04.011","volume":"81","author":"F Asghari","year":"2016","unstructured":"Asghari F, Haghnavaz N, Baradaran B, Hemmatzadeh M, Kazemi T. Tumor suppressor microRNAs: targeted molecules and signaling pathways in breast cancer. Biomed Pharmacother. 2016;81:305\u201317.","journal-title":"Biomed Pharmacother"},{"key":"300_CR20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","volume":"4","author":"YS Lee","year":"2009","unstructured":"Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199\u2013227.","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"300_CR21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.canlet.2013.06.018","volume":"339","author":"Y Li","year":"2013","unstructured":"Li Y, Wang Y, Yu L, Sun C, Cheng D, Yu S, Wang Q, Yan Y, Kang C, Jin S, An T, Shi C, Xu J, Wei C, Liu J, Sun J, Wen Y, Zhao S, Kong Y. miR-146b-5p inhibits glioma migration and invasion by targeting MMP16. Cancer Lett. 2013;339(2):260\u20139.","journal-title":"Cancer Lett"},{"issue":"6","key":"300_CR22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1673-8527(09)60053-9","volume":"37","author":"M Liu","year":"2010","unstructured":"Liu M, Chen H. The role of microRNAs in colorectal cancer. J Genet Genomics. 2010;37(6):347\u201358.","journal-title":"J Genet Genomics"},{"issue":"1","key":"300_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-008-9624-3","volume":"90","author":"J Pierson","year":"2008","unstructured":"Pierson J, Hostager B, Fan R, Vibhakar R. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neuro-Oncol. 2008;90(1):1\u20137.","journal-title":"J Neuro-Oncol"},{"issue":"22","key":"300_CR24","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.febslet.2011.10.025","volume":"585","author":"TC Huang","year":"2011","unstructured":"Huang TC, Chang HY, Chen CY, Wu PY, Lee H, Liao YF, Hsu WM, Huang HC, Juan HF. Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR. FEBS Lett. 2011;585(22):3582\u20136.","journal-title":"FEBS Lett"},{"key":"300_CR25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1741-7015-6-14","volume":"6","author":"J Silber","year":"2008","unstructured":"Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008;6:14.","journal-title":"BMC Med"},{"key":"300_CR26","doi-asserted-by":"publisher","unstructured":"Zhang YH, Wang QQ, Li H, Ye T, Gao F, Liu YC. miR-124 radiosensitizes human esophageal cancer cell TE-1 by targeting CDK4. Genet Mol Res. 2016;15(2). doi: 10.4238\/gmr.15027893 .","DOI":"10.4238\/gmr.15027893"},{"issue":"6","key":"300_CR27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ejca.2010.11.026","volume":"47","author":"A Fowler","year":"2011","unstructured":"Fowler A, Thomson D, Giles K, Maleki S, Mreich E, Wheeler H, Leedman P, Biggs M, Cook R, Little N, Robinson B, McDonald K. miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur J Cancer. 2011;47(6):953\u201363.","journal-title":"Eur J Cancer"},{"issue":"35","key":"300_CR28","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1038\/onc.2012.425","volume":"32","author":"XB Shi","year":"2013","unstructured":"Shi XB, Xue L, Ma AH, Tepper CG, Gandour-Edwards R, Kung HJ, deVere White RW. Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene. 2013;32(35):4130\u20138.","journal-title":"Oncogene"},{"key":"300_CR29","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1038\/cddis.2013.186","volume":"4","author":"H Zhou","year":"2013","unstructured":"Zhou H, Ma H, Wei W, Ji D, Song X, Sun J, Zhang J, Jia L. B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1. Cell Death Dis. 2013;4:e654.","journal-title":"Cell Death Dis"},{"issue":"11","key":"300_CR30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/iub.1080","volume":"64","author":"H Zhou","year":"2012","unstructured":"Zhou H, Zhang Z, Liu C, Jin C, Zhang J, Miao X, Jia L. B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562\/adriamycin-resistant cell line. IUBMB Life. 2012;64(11):889\u2013900.","journal-title":"IUBMB Life"},{"key":"300_CR31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-014-0070-8","volume":"7","author":"AD Smith","year":"2014","unstructured":"Smith AD, Roda D, Yap TA. Strategies for modern biomarker and drug development in oncology. J Hematol Oncol. 2014;7:70.","journal-title":"J Hematol Oncol"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-016-0300-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T08:55:28Z","timestamp":1568278528000},"score":1,"resource":{"primary":{"URL":"http:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-016-0300-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1186\/s13045-016-0300-3","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,12]]},"article-number":"69"}}